BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 29196252)

  • 21. Management of atypical and malignant meningiomas: role of high-dose, 3D-conformal radiation therapy.
    Hug EB; Devries A; Thornton AF; Munzenride JE; Pardo FS; Hedley-Whyte ET; Bussiere MR; Ojemann R
    J Neurooncol; 2000 Jun; 48(2):151-60. PubMed ID: 11083080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adjuvant radiotherapy for atypical meningiomas.
    Bagshaw HP; Burt LM; Jensen RL; Suneja G; Palmer CA; Couldwell WT; Shrieve DC
    J Neurosurg; 2017 Jun; 126(6):1822-1828. PubMed ID: 27611201
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early adjuvant radiotherapy in the treatment of atypical meningioma.
    Jenkinson MD; Waqar M; Farah JO; Farrell M; Barbagallo GM; McManus R; Looby S; Hussey D; Fitzpatrick D; Certo F; Javadpour M
    J Clin Neurosci; 2016 Jun; 28():87-92. PubMed ID: 26775147
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atypical and malignant meningiomas: Considerations for treatment and efficacy of radiotherapy.
    Cain SA; Smoll NR; Van Heerden J; Tsui A; Drummond KJ
    J Clin Neurosci; 2015 Nov; 22(11):1742-8. PubMed ID: 26213286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adjuvant radiotherapy improves progression-free survival in intracranial atypical meningioma.
    Hemmati SM; Ghadjar P; Grün A; Badakhshi H; Zschaeck S; Senger C; Acker G; Misch M; Budach V; Kaul D
    Radiat Oncol; 2019 Sep; 14(1):160. PubMed ID: 31477146
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Management of WHO grade II and II meningiomas: retrospective study of surgical series of 36 cases at a single institution].
    Duntze J; Metellus P; Litre CF; Eap C; Theret E; Colin P; Peruzzi P; Rousseaux P
    Neurochirurgie; 2012 Oct; 58(5):275-81. PubMed ID: 22425580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progression-Free Survival and Factors Associated with Postoperative Recurrence in 126 Patients with Atypical Intracranial Meningioma.
    Phonwijit L; Khawprapa C; Sitthinamsuwan B
    World Neurosurg; 2017 Nov; 107():698-705. PubMed ID: 28838877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Simpson grading revisited: aggressive surgery and its place in modern meningioma management.
    Gousias K; Schramm J; Simon M
    J Neurosurg; 2016 Sep; 125(3):551-60. PubMed ID: 26824369
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intracranial meningeal hemangiopericytoma: 10 years experience of a tertiary care Institute.
    Kumar N; Kumar R; Kapoor R; Ghoshal S; Kumar P; Salunke PS; Radotra BD; Sharma SC
    Acta Neurochir (Wien); 2012 Sep; 154(9):1647-51. PubMed ID: 22790838
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surgical resection and permanent brachytherapy for recurrent atypical and malignant meningioma.
    Ware ML; Larson DA; Sneed PK; Wara WW; McDermott MW
    Neurosurgery; 2004 Jan; 54(1):55-63; discussion 63-4. PubMed ID: 14683541
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surgical Resection and Interstitial Iodine-125 Brachytherapy for High-Grade Meningiomas: A 25-Year Series.
    Magill ST; Lau D; Raleigh DR; Sneed PK; Fogh SE; McDermott MW
    Neurosurgery; 2017 Mar; 80(3):409-416. PubMed ID: 27258768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic Value of Ki-67 Labeling Index and Postoperative Radiotherapy in WHO Grade II Meningioma.
    Choi Y; Lim DH; Yu JI; Jo K; Nam DH; Seol HJ; Lee JI; Kong DS; Suh YL; Nam H
    Am J Clin Oncol; 2018 Jan; 41(1):18-23. PubMed ID: 26270441
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recurrence of cranial base meningiomas.
    Mathiesen T; Lindquist C; Kihlström L; Karlsson B
    Neurosurgery; 1996 Jul; 39(1):2-7; discussion 8-9. PubMed ID: 8805134
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined proton and photon conformal radiotherapy for intracranial atypical and malignant meningioma.
    Boskos C; Feuvret L; Noel G; Habrand JL; Pommier P; Alapetite C; Mammar H; Ferrand R; Boisserie G; Mazeron JJ
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):399-406. PubMed ID: 19203844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic Factors, Survival, and Treatment for Intracranial World Health Organization Grade II Chordoid Meningiomas and Clear-Cell Meningiomas.
    Zhang GJ; Zhang YS; Zhang GB; Yan XJ; Li CB; Zhang LW; Li D; Wu Z; Zhang JT
    World Neurosurg; 2018 Sep; 117():e57-e66. PubMed ID: 29859361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recurrence pattern analysis after [
    Zollner B; Ganswindt U; Maihöfer C; Corradini S; Albert NL; Schichor C; Belka C; Niyazi M
    Radiat Oncol; 2018 Jun; 13(1):110. PubMed ID: 29898747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atypical and malignant meningioma: outcome and prognostic factors in 68 irradiated patients.
    Detti B; Scoccianti S; Di Cataldo V; Monteleone E; Cipressi S; Bordi L; Pellicanò G; Gadda D; Saieva C; Greto D; Pecchioli G; Buccoliero A; Ceroti M; Ammannati F; Biti G
    J Neurooncol; 2013 Dec; 115(3):421-7. PubMed ID: 24045968
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Brachytherapy with surgical resection as salvage treatment for recurrent high-grade meningiomas: a matched cohort study.
    Mooney MA; Bi WL; Cantalino JM; Wu KC; Harris TC; Possatti LL; Juvekar P; Hsu L; Dunn IF; Al-Mefty O; Devlin PM
    J Neurooncol; 2020 Jan; 146(1):111-120. PubMed ID: 31745706
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atypical meningioma: a study of prognostic factors.
    Zaher A; Abdelbari Mattar M; Zayed DH; Ellatif RA; Ashamallah SA
    World Neurosurg; 2013 Nov; 80(5):549-53. PubMed ID: 23871812
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-Term Outcomes of Newly Diagnosed Resected Atypical Meningiomas and the Role of Adjuvant Radiotherapy.
    Zhi M; Girvigian MR; Miller MJ; Chen JC; Schumacher AJ; Rahimian J; Lodin K
    World Neurosurg; 2019 Feb; 122():e1153-e1161. PubMed ID: 30447464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.